Zalicus Inc (NASDAQ:ZLCS)
| 0.5901 Data as of May 24 |  -0.0015 / -0.25%Today’s Change | 0.43 Today|||52-Week Range 1.62 | -9.22% Year-to-Date |
Latest ZLCS News | Press Releases
No recent news for Zalicus Inc.
Today’s Trading
| Previous close | 0.59 |
| Today’s open | 0.59 |
| Day’s range | 0.58 - 0.61 |
| Volume | 227,348 |
| Average volume (3 months) | 579,949 |
| Market cap | $75.1M |
| Dividend yield | -- |
Data as of 3:59pm ET, 05/24/2013
Growth & Valuation
| Earnings growth (last year) | +11.63% |
| Earnings growth (this year) | +29.61% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +53.35% |
| P/E ratio | NM |
| Price/Sales | 6.08 |
| Price/Book | 2.42 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CBLICleveland BioLabs In... | +0.02 | +1.22% |
| MDGNMedgenics Inc | -0.06 | -1.44% |
| --Ophthalix Inc | 0.00 | 0.00% |
| APRIApricus Biosciences ... | -0.07 | -2.64% |
Data as of 4:00pm ET, 05/24/2013
Financials
| Next reporting date | August 7, 2013 |
| EPS forecast (this quarter) | -$0.08 |
| Annual revenue (last year) | $12.6M |
| Annual profit (last year) | -$44.3M |
| Net profit margin | -353.20% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
President, Chief Executive Officer & Director Mark H. N. Corrigan, MD |
Chief Financial Officer, Treasurer & Executive VP Justin A. Renz, MBA, CPA |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
